Middle East Healthcare Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA141H01UKH9
SAR
34.40
-0.08 (-0.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
791.13
733.74
748.88
732.07
712.66
689.21
719.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
791.13
733.74
748.88
732.07
712.66
689.21
719.81
Raw Material Cost
486.21
452.99
469.75
441.90
436.45
431.39
426.95
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
49.45
53.26
46.83
46.63
62.17
66.17
51.86
Selling and Distribution Expenses
193.58
179.20
177.44
174.29
170.48
140.18
205.71
Other Expenses
-4.95
-5.33
-4.68
-4.66
-6.22
-6.62
-5.19
Total Expenditure (Excl Depreciation)
679.79
632.19
647.19
616.19
606.93
571.57
632.66
Operating Profit (PBDIT) excl Other Income
111.30000000000001
101.5
101.7
115.9
105.7
117.6
87.2
Other Income
7.32
119.43
54.29
5.67
23.86
7.73
4.09
Operating Profit (PBDIT)
179.67
278.83
213.85
175.82
182.85
176.70
140.85
Interest
49.45
53.26
46.83
46.63
62.17
66.17
51.86
Exceptional Items
2.73
0.46
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
304.92
280.75
279.13
290.17
276.21
257.82
292.86
Depreciation
61.01
57.85
57.88
54.27
53.27
51.33
49.60
Profit Before Tax
71.94
168.17
109.15
74.92
67.42
59.19
39.39
Tax
5.33
5.27
0.81
10.98
7.26
7.22
3.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
63.67
160.13
107.14
61.74
61.17
51.94
36.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
63.67
160.13
107.14
61.74
61.17
51.94
36.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.65
2.57
0.68
2.19
-1.02
0.03
-1.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
66.31
162.71
107.82
63.94
60.15
51.97
35.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,803.59
1,786.20
1,626.11
1,699.33
1,636.63
1,572.12
1,519.08
Earnings per share (EPS)
0.69
1.74
1.16
0.67
0.66
0.56
0.4
Diluted Earnings per share
0.69
1.74
1.16
0.67
0.66
0.56
0.4
Operating Profit Margin (Excl OI)
14.07%
13.84%
13.58%
15.83%
14.84%
17.07%
12.11%
Gross Profit Margin
16.81%
30.8%
22.3%
17.65%
16.93%
16.04%
12.36%
PAT Margin
8.05%
21.82%
14.31%
8.43%
8.58%
7.54%
5.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 11.00% vs 14.16% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 10.13% vs 43.33% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 8.36% vs 34.97% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -20.42% vs 146.83% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Middle East Healthcare Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
791.13
0
791.13
Other Operating Income
0.00
0.00
0.00
Total Operating income
791.13
0
791.13
Raw Material Cost
486.21
0
486.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
49.45
0
49.45
Selling and Distribution Expenses
193.58
0
193.58
Other Expenses
-4.95
0.00
-4.95
Total Expenditure (Excl Depreciation)
679.79
0
679.79
Operating Profit (PBDIT) excl Other Income
111.34
0.00
111.34
Other Income
7.32
0
7.32
Operating Profit (PBDIT)
179.67
0
179.67
Interest
49.45
0
49.45
Exceptional Items
2.73
0
2.73
Gross Profit (PBDT)
304.92
0
304.92
Depreciation
61.01
0
61.01
Profit Before Tax
71.94
0
71.94
Tax
5.33
0
5.33
Provisions and contingencies
0
0
0.00
Profit After Tax
63.67
0
63.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
63.67
0
63.67
Share in Profit of Associates
0
0
0.00
Minority Interest
2.65
0
2.65
Other related items
0.00
0.00
0.00
Consolidated Net Profit
66.31
0
66.31
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,803.59
0
1,803.59
Earnings per share (EPS)
0.69
0
0.69
Diluted Earnings per share
0.69
0
0.69
Operating Profit Margin (Excl OI)
14.07%
0%
0.00
14.07%
Gross Profit Margin
16.81%
0%
0.00
16.81%
PAT Margin
8.05%
0%
0.00
8.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 79.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 7.82% vs -2.03% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.00% vs 14.16% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.63 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -59.25% vs 50.93% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.13% vs 43.33% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 8.09% vs -0.13% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 8.36% vs 34.97% in Jun 2024

Quarterly - Interest
Interest 4.95 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -7.13% vs 13.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -20.42% vs 146.83% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.07%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024